Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 101 - 150 out of 2,528

Document Document Title
WO/2012/059436A2
The invention relates to novel compounds of formula (I), in which R1, R2, R3, R4, R5, Y, Q and G are defined as indicated above, to several methods and intermediate products for the production thereof and use thereof as herbicides and/or...  
WO/2011/152658A3
The present invention relates to a pharmaceutical composition for treating or preventing type II diabetes mellitus comprising piperazine dithioctate and glimepiride, which is a new combination drug. The pharmaceutical composition of the ...  
WO/2011/133893A3
The invention provides salts of sulfanegen and methods for their use.  
WO/2011/107881A3
A compound, composition, method of synthesizing and using the compound of formula 1 are disclosed. The compound of formula I also comprises of salts, polymorphs, solvates, and hydrates thereof. The compound may be formulated as pharmaceu...  
WO/2012/024083A1
Novel derivatives of dihydro-l,4,2-oxathiazine and dihydro-l,4-dithiine oxides, more particularly, novel derivatives of dihydro-l,4,2-oxathiazine and dmydro-l,4-dithiine oxides that target cysteine residues of biomolecules of pharmacolog...  
WO/2012/014746A1
Provided are an α-lipoic acid complex obtained by complexing R-α-lipoic acid or S-α-lipoic acid, R-dihdyro-α-lipoic acid or S-dihdyro-α-lipoic acid, or an alkali metal salt or an alkaline earth metal salt thereof, and a method for p...  
WO/2011/107867A3
A compound, composition and method of making and using a compound of formula (1) are disclosed. The compound of formula I also comprises of salts, polymorphs, solvates, mesylates, hydrochloric salt, solvates and hydrates thereof. The com...  
WO/2011/107870A3
A compound, composition, method of synthesizing and using the compound of formula (I) are disclosed. The compound of formula (I) also comprises of salts, polymorphs, solvates, and hydrates thereof. The compound may be formulated as pharm...  
WO/2011/154833A1
The disclosure herein provides a compound of formula I or its pharmaceutical acceptable salts, as well as polymorphs, solvates, and hydrates thereof. The steps of synthesis of compound of formula I is described. These salts may be formul...  
WO/2011/152658A2
The present invention relates to a pharmaceutical composition for treating or preventing type II diabetes mellitus comprising piperazine dithioctate and glimepiride, which is a new combination drug. The pharmaceutical composition of the ...  
WO/2009/023160A8
The present disclosure describes novel small-molecule inhibitors of bacterial sortases. The identified inhibitors may be used in the methods of treatment and prevention described in the present disclosure.  
WO/2011/133893A2
The invention provides salts of sulfanegen and methods for their use.  
WO/2011/128301A1
The invention relates to the use of novel and known dithiin derivatives for controlling undesirable microorganisms, in particular phytopathogenic fungi, in crop protection, in the area of household and hygiene and in material protection,...  
WO/2011/121077A1
The present invention relates to a multisensor array for detection of analytes in the gas phase or in the liquid phase, comprising at least two different chemo-selective compounds represented by the general formula (I) wherein the hetero...  
WO/2011/117749A1
The disclosure herein provides a compound of formula (1). The disclosure also provides a method of synthesizing the compound of formula (1). The compound of formula (1) or its pharmaceutical acceptable salts, as well as polymorphs, solva...  
WO/2011/114792A1
Disclosed are a dispersion of fine particles of a substituted benzenedithiol metal complex, which is maintained in a stable dispersion state without reaggregation for a long period of time, has long-lasting excellent light resistance, an...  
WO/2011/107870A2
A compound, composition, method of synthesizing and using the compound of formula (I) are disclosed. The compound of formula (I) also comprises of salts, polymorphs, solvates, and hydrates thereof. The compound may be formulated as pharm...  
WO/2010/071988A8
Described herein are routes of synthesis and therapeutic uses of 1-alkyl, 2-acyl glycerol derivatives of formula I: which when administered to mammalian biological systems result in increased cellular concentrations of specific sn-2 subs...  
WO/2010/151008A9
The present invention relates to piperazine dithioctate, a novel addition salt of thioctic acid with a base and a pharmaceutical composition comprising the same. The piperazine dithioctate according to the present invention has good ther...  
WO/2011/078785A1
The present invention relates to novel compounds, and in particular to diacylglycerol (1, 3-DAG) and alpha-lipoic acid (LA) and/or dihydro-alpha-lipoic acid (DHLA) derivatives. In particular these novel compounds are used as functional f...  
WO/2010/149675A3
A method of synthesizing organic molecules is provided, wherein the method comprises providing an electrophilic educt, providing an ionic liquid comprising a carbanion, and synthesizing the organic molecules by mixing the electrophilic e...  
WO/2010/151008A3
The present invention relates to piperazine dithioctate, a novel addition salt of thioctic acid with a base and a pharmaceutical composition comprising the same. The piperazine dithioctate according to the present invention has good ther...  
WO/2011/030645A1
Disclosed is a photopolymerizable composition which contains (A) a photopolymerization initiator that has a partial structure represented by general formula (1) and (B) a polymerizable compound. In general formula (1), R3 and R4 each ind...  
WO/2011/017538A1
This present disclosure is related to the field of N1-acyl-5-fluoropyrimidinones and their derivatives and to the use of these compounds as fungicides.  
WO/2011/017547A1
This present disclosure is related to the field of N1-sulfonyl-5-fluoropyrimidinones and their derivatives and to the use of these compounds as fungicides.  
WO/2011/017544A1
This present disclosure is related to the field of 5-fluoro-2-oxopyrimidine-1-(2H)-carboxylates and their derivatives and to the use of these compounds as fungicides.  
WO/2011/017540A1
This present disclosure is related to the field of 5-fluoropyrimidinones and their derivatives and to the use of these compounds as fungicides.  
WO/2010/149675A2
A method of synthesizing organic molecules is provided, wherein the method comprises providing an electrophilic educt, providing an ionic liquid comprising a carbanion, and synthesizing the organic molecules by mixing the electrophilic e...  
WO/2010/151008A2
The present invention relates to piperazine dithioctate, a novel addition salt of thioctic acid with a base and a pharmaceutical composition comprising the same. The piperazine dithioctate according to the present invention has good ther...  
WO/2010/129596A1
Compounds that modulate pyruvate kinase M2 (PKM2) are described herein. Also described herein are pharmaceutical compositions comprising the compounds, and methods of using the compounds in the treatment of cancer.  
WO/2010/110771A2
An improved process for the synthesis of derivatives of substituted thiol-containing alkyl fatty acids, such as but not limited to lipoic acid, generates intermediate compounds and occurs in a temperature-controlled optimal sequence of m...  
WO/2010/110351A1
A tetrathiafulvalene derivative expressed by General Formula (I): General Formula (I) in General Formula (I), X represents an atom selected from a carbon atom, a sulfur atom, and a nitrogen atom, and Xs may be the same or different; prov...  
WO/2010/100833A1
Provided are 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivatives which serve as monofluoromethylating agents useful a intermediates in the synthesis of drugs or agricultural chemicals; a process for the preparation of the derivative...  
WO/2009/109501A3
The present invention relates to novel derivatives of opthalmic compounds for the treatment of ocular diseases.  
WO/2009/111037A3
The disclosures herein provide lipoic acid salts, as well as polymorphs, solvates, and hydrates thereof. These salts may be formulated as pharmaceutical compositions. The pharmaceutical compositions may be formulated for oral administrat...  
WO/2010/071988A1
Described herein are routes of synthesis and therapeutic uses of 1-alkyl, 2-acyl glycerol derivatives of formula I: which when administered to mammalian biological systems result in increased cellular concentrations of specific sn-2 subs...  
WO/2010/056726A1
The disclosures herein provide lipoic acid salts, as well as polymorphs, solvates, and hydrates thereof. These salts may be formulated as pharmaceutical compositions. The pharmaceutical compositions may be formulated for oral administrat...  
WO/2010/052310A1
The present invention concerns an enantiomer R of a compound of Formula (I), wherein X is -NH-R1 or of Formula (V) or (VI), R1 is -(CH2)n-R2, R2 is a linear, branched or cyclic C1C6 aliphatic group, -O-(CH2)n-CH3, -NH-CO- (CH2)n-CH3, a 5...  
WO/2010/048694A1
A polymer of formula (I): where: n is an integer from 10 to 5,000; m is an integer from 10 to 5,000; Ar1 and Ar3 are the same or different and are residues derived from a tetra-hydroxy aromatic monomer, the tetra-hydroxy aromatic monomer...  
WO/2010/040603A1
The present invention relates to novel dithiolane compounds of formula (I) below: formula (I), in which Y denotes 0, NR1 or S; R1 denotes a hydrogen atom; a saturated linear C1-C20 or branched C3-C20 or unsaturated C2-C20 alkyl hydrocarb...  
WO/2010/002474A1
The invention provides β-sulfonamide α-keto esters and amides in which the α-keto is protected as a 1,3-dithiolane derivative. Also provided are methods for preparing such esters and amides and for incorporating them into peptides.  
WO/2010/001587A1
Disclosed is a norbornene compound having a sulfur atom, which can be produced by using a starting compound that can be synthesized readily and has a polymerizable double bond and a sulfur atom. The norbornene compound is represented by...  
WO/2009/151061A1
A high-refractive-index compound is provided which has a new type of polymerizability and is useful as an optical material. Also provided is a holographic recording medium which contains the compound and thereby has a high efficiency of...  
WO/2009/150074A1
Compounds of the formula (I), wherein R1, R2 and R3 for example are hydrogen, halogen, CN, C1-C18alkyl, C1-C10 haloalkyl, (CO)R8, (CO)OR4, or (CO)NR5R6; Y is O, S or CO; D2, D3 and D4 for example are a direct bond, O, S, NR7, CO, O(CO), ...  
WO/2009/148698A1
The present invention describes nanoprodrugs of non-steroidal anti-inflammatory drug (NSAIDs) and nanoprodrugs of α-lipoic acid-containing and NSAIDs. These nanoprodrugs have antioxidant properties and stimuli-responsiveness, which can ...  
WO/2009/144801A1
This invention provides a dithiane derivative, which is useful for enhancing the refractive index of a resist base material resin without sacrificing transparency and an acid reactivity necessary for the resist, and a polymer comprising ...  
WO/2009/117902A1
Provided herein are 5-demethoxyfumagillol and its derivatives. Also provided herein are methods of making the 5-demethoxyfumagillol and derivatives. Also provided herein are biological activities of the 5-demethoxyfumagillol and derivati...  
WO/2009/109501A2
The present invention relates to novel derivatives of opthalmic compounds for the treatment of ocular diseases.  
WO/2009/111635A2
Dithiol compounds and derivatives thereof are disclosed. The agents are useful for treating ocular disease, especially presbyopia and cataract.  
WO/2009/111633A2
Novel mercaptan compounds, particularly those including a photolabile protecting group, are described as well as methods of using the compounds for the prevention and treatment of ocular damage and disease.  

Matches 101 - 150 out of 2,528